These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25787305)
1. Potassium 2-(1-hydroxypentyl)-benzoate inhibits ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathways. Yang H; Xu S; Li J; Wang L; Wang X Naunyn Schmiedebergs Arch Pharmacol; 2015 Sep; 388(9):983-90. PubMed ID: 25787305 [TBL] [Abstract][Full Text] [Related]
2. The naphthoquinone plumbagin suppresses ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathway. Zhang Q; Liao X; Wu F Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):573-578. PubMed ID: 28650323 [TBL] [Abstract][Full Text] [Related]
3. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia. Zhang Y; Wang L; Li J; Wang XL J Pharmacol Exp Ther; 2006 Jun; 317(3):973-9. PubMed ID: 16527903 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography. Khanna V; Armstrong PC; Warner TD; Curzen N Platelets; 2015; 26(7):689-92. PubMed ID: 25734957 [TBL] [Abstract][Full Text] [Related]
5. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246 [TBL] [Abstract][Full Text] [Related]
6. Potassium 2-(1-hydroxypentyl)-benzoate attenuated hydrogen peroxide-induced apoptosis in neuroblastoma SK-N-SH cells. Hu Y; Peng Y; Long Y; Xu S; Feng N; Wang L; Wang X Eur J Pharmacol; 2012 Apr; 680(1-3):49-54. PubMed ID: 22329894 [TBL] [Abstract][Full Text] [Related]
7. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1. Fox SC; Behan MW; Heptinstall S Cell Calcium; 2004 Jan; 35(1):39-46. PubMed ID: 14670370 [TBL] [Abstract][Full Text] [Related]
9. Potassium 2-(1-hydroxypentyl)-benzoate improves learning and memory deficits in chronic cerebral hypoperfused rats. Zhao W; Xu S; Peng Y; Ji X; Cao D; Li J; Liu B; Shi Q; Wang L; Wang X Neurosci Lett; 2013 Apr; 541():155-60. PubMed ID: 23416317 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the aggregation responses of camel platelets. Al Ghumlas AK; Gader AG Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654 [TBL] [Abstract][Full Text] [Related]
11. Role of intracellular signaling events in ADP-induced platelet aggregation. Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922 [TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation. Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430 [TBL] [Abstract][Full Text] [Related]
13. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Fälker K; Lange D; Presek P Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804 [TBL] [Abstract][Full Text] [Related]
14. P2Y12, a new platelet ADP receptor, target of clopidogrel. Herbert JM; Savi P Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474 [TBL] [Abstract][Full Text] [Related]
15. Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs. Li J; Xu SF; Peng Y; Feng N; Wang L; Wang XL Acta Pharmacol Sin; 2018 Feb; 39(2):275-285. PubMed ID: 28905934 [TBL] [Abstract][Full Text] [Related]
16. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists. Khan N; Farooq AD; Sadek B Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418 [TBL] [Abstract][Full Text] [Related]
17. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition. Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412 [TBL] [Abstract][Full Text] [Related]
18. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species. Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866 [TBL] [Abstract][Full Text] [Related]
19. Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice. Li PP; Wang WP; Liu ZH; Xu SF; Lu WW; Wang L; Wang XL Acta Pharmacol Sin; 2014 Jul; 35(7):869-78. PubMed ID: 24858312 [TBL] [Abstract][Full Text] [Related]
20. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]